OC 54 - Outcomes in Patients with Cancer Associated Thrombosis I

Moderator(s)

• 

  Vicky Tagalakis, MD MSc (she/her/hers)

  Associate Professor
  McGill University
  Montreal, Quebec, Canada
• 

  Federico Germini, MD, MSc, PhD

  Assistant Professor
  Department of Medicine, McMaster University, Hamilton, ON
  Hamilton, Ontario, Canada

Presentations:

• 10:45 – 11:00 ET

  Effectiveness and Safety of Rivaroxaban and Low Molecular-Weight Heparin in Cancer-Associated Venous Thromboembolism: A Meta-Analysis of OSCAR Programme Findings
  

  Presenting Author: Craig I. Coleman, PharmD – University of Connecticut

  Co-Author: Kimberly Snow-Caroti – Evidence-Based Practice Center, Hartford Hospital

  Co-Author: Khaled Abdelgawwad, MSc, MBA – Bayer AG

  Co-Author: George Psaroudakis – Bayer AG

  Co-Author: Marcela Rivera – Janssen Pharmaceuticals

  Co-Author: Bernhard Schaefer – Bayer AG

  Co-Author: Gunnar Brobert – Bayer AG

  Co-Author: Alok A. Khorana, MD (he/him/his) – Cleveland Clinic and Case Comprehensive Cancer Center

  Co-Author: Cecilia Becattini, PhD – University of Perugia

  Co-Author: Agnes Y.Y Lee, MD MSc (she/her/hers) – University of British Columbia

  Co-Author: Anders Ekbom – Karolinska Institute

  Co-Author: Marie Linder – Karolinska Institute

  Co-Author: Marc Carrier, MD – Ottawa Hospital Research Institute, Ottawa, ON, Canada

  Co-Author: Cihan Ay, MD (he/him/his) – Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria

  Co-Author: Christopher Wallenhorst – Institute for Epidemiology, Statistics and Informatics GmbH

  Co-Author: Carlos Martinez – Institute for Epidemiology, Statistics and Informatics GmbH

  Co-Author: Christopher Brescia – Freshtech IT

  Co-Author: Alexander T. Cohen – Guy's and St Thomas' NHS Foundation Trust, King's College London, UK
• 11:00 – 11:15 ET

  Comparison of Direct Oral Anticoagulants versus Low Molecular Weight Heparin in Primary and Metastatic Brain Cancers: A Meta-Analysis and Systematic Review
  

  Co-Author: Varun Iyengar – Department of Internal Medicine, Beth Israel Deaconess Medical Center, Boston, MA

  Presenting Author: Shubham Agrawal, MBBS (he/him/his) – Department of Internal Medicine, Mercy Catholic Medical Center, Darby, PA

  Co-Author: Thita Chiasakul – Division of Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand

  Co-Author: Kian Tehranchi – Department of Internal Medicine, Beth Israel Deaconess Medical Center, Boston, MA

  Co-Author: Megan Mcnichol – Division of Knowledge Services, Department of Information Services, Beth Israel Deaconess Medical Center, Boston, MA

  Co-Author: Brian J. Carney – Division of Hematology and Hematologic Malignancies, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, USA

  Co-Author: Avi Leader, MD (he/him/his) – Institute of Hematology, Rabin Medical Center, Petah Tikva

  Co-Author: Jeffrey I. Zwicker, MD – Department of Medicine, Hematology Service, Memorial Sloan Kettering Cancer Center, New York City, NY

  Co-Author: Rushad Patell, MD (he/him/his) – Beth Israel Deaconess Medical Center, Boston, MA, USA
• 11:15 – 11:30 ET

  Direct oral anticoagulants vs low molecular weight heparin in the management of patients with primary or metastatic brain tumours: a systematic review and meta-analysis
  

  Co-Author: Wendy Yu – Faculty of Medicine, University of Ottawa

  Co-Author: Jayhan Kherani – McMaster University, Faculty of Health Sciences

  Co-Author: Daniel C. Tham (he/him/his) – Faculty of Medicine, University of Ottawa

  Co-Author: Lucy Zhao (she/her/hers) – McMaster University

  Co-Author: Pei Ye Li, MD(c), MEng – Temerty Faculty of Medicine, University of Toronto

  Presenting Author: Ali Eshaghpour, MD (he/him/his) – Department of Medicine, McMaster University

  Co-Author: Mark Crowther, MD MSc – Department of Medicine, McMaster University

  Co-Author: Allen Li – McMaster University, Department of Medicine
• 11:30 – 11:45 ET

  Multinational Cohort Analysis of Intracranial Hemorrhage Outcomes in Patients with Brain Tumors Receiving Anticoagulation (ABC Study)
  

  Presenting Author: Avi Leader, MD (he/him/his) – Institute of Hematology, Rabin Medical Center, Petah Tikva

  Co-Author: Eva N. Hamulyák – Department of Vascular Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands

  Co-Author: Tzu-Fei Wang, MD, MPH (she/her/hers) – Department of Medicine, University of Ottawa at The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, ON, Canada

  Co-Author: Lisa Baumann Kreuziger, MD, MS (she/her/hers) – Versiti Blood Research Institute, Versiti, Milwaukee, WI, USA

  Co-Author: Brian J. Carney – Division of Hematology and Hematologic Malignancies, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, USA

  Co-Author: Ann Hoeben – Division of Medical Oncology, Department of Internal Medicine, GROW-School of Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands

  Co-Author: Berna C. Özdemir – Department of Medical Oncology, Inselspital Bern, Bern University Hospital, University of Bern, Switzerland

  Co-Author: Rosana D. Cordova Serrano – Hematology Department, Instituto Nacional de Cancerología, Mexico City, Mexico

  Co-Author: Kristen Sanfilippo, MD, MPHS (she/her/hers) – Washington Univesrity

  Co-Author: Shira Rozenblatt – Department of Radiology, Rabin Medical Center, Petah Tikva, Israel

  Co-Author: Ludo F. M. Beenen – Department of Radiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands

  Co-Author: Shlomit Yust-Katz – Neurooncology Unit, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel

  Co-Author: Erez Halperin – Institute of Hematology, Rabin Medical Center, Petah Tikva and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

  Co-Author: Ariela Arad – Hematology Department, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  Co-Author: Aharon Lubetsky – National Hemophilia Center and Thrombosis & Hemostasis Institute, Sheba Medical Center, Israel. Sackler Faculty of Medicine, Tel Aviv University, Israel.

  Co-Author: Marc Carrier, MD – Ottawa Hospital Research Institute, Ottawa, ON, Canada

  Co-Author: Benjamin Massat – Versiti, Medical College of Wisconsin, Milwaukee, WI, USA

  Co-Author: Harry R. Büller – Department of Vascular Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands

  Co-Author: Galia Spectre, MD PhD – Institute of Hematology, Rabin Medical Center, Petah Tikva

  Co-Author: Jeffrey I. Zwicker, MD – Department of Medicine, Hematology Service, Memorial Sloan Kettering Cancer Center, New York City, NY
• 11:45 – 12:00 ET

  Association of Inferior Vena Cava Filter (IVCF) Use and 30-Day Mortality and 180-Day Intracranial Hemorrhage among Patients with Brain Metastasis and Venous Thromboembolism: an Updated Analysis
  

  Co-Author: Renata Abrahao – University of California Davis Comprehensive Cancer Center, Division of Hematology and Oncology

  Co-Author: Ann Brunson – University of California Davis Comprehensive Cancer Center, Division of Hematology and Oncology

  Co-Author: Vaibhav Kumar – University of North Carolina Lineberger Comprehensive Cancer Center

  Co-Author: Anjlee Mahajan – University of California Davis Comprehensive Cancer Center, Division of Hematology and Oncology

  Co-Author: Nigel S. Key – Division of Hematology, University of North Carolina, Chapel Hill, NC, USA

  Co-Author: Theresa Keegan – University of California Davis Comprehensive Cancer Center, Division of Hematology and Oncology

  Presenting Author: Ted Wun, MD (he/him/his) – University of California Davis Comprehensive Cancer Center, Division of Hematology and Oncology